GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative

Volume 13 / Year 2024 / Issue 3

Review Article

A review of international initiatives on pharmaceutical regulatory reliance and recognition

Author(s): Vimal Sachdeva, MSc

Page: 152-60

Abstract: In light of recent global health challenges, the need for regulatory reliance – where one regulatory authority accepts the decisions of another – has gained significant interest and momentum. A fundamental role of any government is to protect its citizens and promote a healthy lifestyle by ensuring the quality, safety, and efficacy of medical […]

Read more →

Aligning environmental, social, and governance to clinical development: moving towards more sustainable clinical trials

Page: 142-51

Author byline as per print journal: Shivani Mittra1, MPharm, PhD; Shylashree Baraskar1, MBBS; Elena Wolff -Holz2, MD; Sandeep N Athalye1, MBBS, MD Abstract: Drug development is among the highest producers of greenhouse gas (GHG) emissions, with about 4.4%–4.6% of the worldwide GHG emissions coming from the thousands of clinical trials being carried out annually by […]

Read more →


Last update: 18/03/2025

Go Back

🖨️ Print